The Effect of Enalapril, Losartan, or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients

Table 2

Biochemical and anthropometric data.

	Not antihypertensive -13			Enalapril -13			Losartan -13
	Baseline	One year	WCX	Baseline	1 year	WCX	Baseline	One year	WCX	K-W
Weight (kg)	^b	^b	0.05			0.2			0.03	0.03
BMI (km/m^2)			0.2			0.9			<0.01	0.05
SBP (mmHg)	^a,b	^a,b	<0.01			<0.01			<0.01	<0.01
DBP (mmHg)	^a,b	^b	0.1			<0.01			<0.01	<0.01
Glucose (mg/dL)			0.03			0.2			0.5	NS
Creatinine (mg/dL)			<0.01			<0.01			<0.01	NS
Urea (mg/dL)	^a		<0.01			<0.01			0.04	0.02
Potassium mmol/L			NS			NS			NS	NS
Leukocytes (%)			0.1			0.3			0.05	0.2
Lymphocytes (%)	^a		0.04	^b		0.5			<0.01	<0.01
Hemoglobin (mg/dL)			<0.01			<0.01			0.02	NS
Hematocrit (%)			0.6			0.1			<0.01	NS
Platelets (μL)	^a,b		<0.01			0.1			0.02	<0.01
TAC levels			NS			NS			NS	NS

The results are expressed as . ^avs. Enalapril. ^bvs. Losartan. Wilcoxon rank test. Kruskal-Wallis test. ^a,^bThe different letter denotes statistically significant difference using the Dunn-Bonferroni paired test. BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; NS: nonsignificant.